{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6IzPgJDA","lastupdate":"2024-02-25T00:00:00.000Z","update_date":"2024-02-25T00:00:00.000Z","lastModified":"Jan 23, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"medasense-biometrics","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$yhgor0aajGD4VqHAyFBWekT83A0RekNKmhdy5KT9iKdtutjy4bWPal","name":"Medasense Biometrics","oneliner":"Noninvasive Pain-monitoring Solutions","registrar":"514156223","website":"https://medasense.com/","careerspage":"https://medasense.com/careers","founded_month":6,"founded_year":2008,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/MedasenseLtd","youtube":"https://www.youtube.com/channel/UCpSvFXsYshTsVS3TCmViRyg","facebook":"https://www.facebook.com/MedasenseBiometricsLtd","linkedin":"https://www.linkedin.com/company/399874","instagram":""},"social":["https://www.linkedin.com/company/399874","https://www.facebook.com/MedasenseBiometricsLtd","https://www.youtube.com/channel/UCpSvFXsYshTsVS3TCmViRyg","https://twitter.com/MedasenseLtd"],"flattenedsociallinks":"https://www.linkedin.com/company/399874|https://www.facebook.com/MedasenseBiometricsLtd|https://www.youtube.com/channel/UCpSvFXsYshTsVS3TCmViRyg|https://twitter.com/MedasenseLtd","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":27,"patent":1,"raised":33500000,"stage":"C","public_stage":"C","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Medasense offers a technology that enables clinicians to optimize and personalize pain control and avoid overmedication.\r\n\r\nMedasense's flagship product, the PMD-200 with its NOL index, is a platform that objectively monitors and quantifies the patient's pain response by means of artificial intelligence and a proprietary noninvasive sensor platform. The PMD-200 is used to optimize pain management in operating rooms and critical care settings, where patients are unable to communicate. \r\n\r\nThe PMD-200 is distributed in Europe exclusively by Medtronic. It is also cleared for marketing in Canada, Latin America, Israel, and Australia. It enables connectivity with Philips patient monitors. Clinical studies have demonstrated its impact on patient safety and outcomes, including opioid sparing.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972737690321","country":null,"address":{"israeli":[{"id":"ea902fdb-c9f6-4cca-b422-2895ebd88542","city":"Ramat Gan","type":null,"address":"Hahilazon Street 4, Ramat Gan, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"6dbe1efc-aca2-4dba-a862-a661de5fadcb","city":"Longmont","address":"1067 South Hover Street, Longmont, CO, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"DUSl6U7TRxR0NUweGdQ44vndxoYSSgfBcdnAAL7wOlebPLyIHRHHzF","date":"Feb 28, 2023","link":"https://www.calcalistech.com/ctechnews/article/hyfvzhsrs","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"FDA clearance, pain management","company":"Medasense Biometrics","layoffs":null,"summary":"Medasense Biometrics has received marketing authorization from the FDA for its PMD-200 patient monitor with NOL technology. The technology uses a sensor platform and AI algorithms to convert data into a patients Signature of Pain and is used for monitoring nociception. It allows clinicians to personalize pain management and avoid overmedication. NOL is the first and only market-authorized technology for assessing changes in nociception in adult patients receiving opioid or opioid sparing analgesics. Medasense aims to improve pain management and pain-related outcomes for patients undergoing surgery.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA clearance","Pain management","NOL technology","Patient monitor","Pain assessment"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rWZrvW0Lqgq4xG04iwOzYCbdfTwaVd8KdrKlLO0HtrsTAb2DCAKMLe","news_summary":"FDA authorizes marketing of Medasense's NOL technology to measure pain in anesthetized patients | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"eee4cf4f-7f2c-4b59-a531-f5b7a2258ec3","date":"Apr 27, 2021","link":"https://www.prnewswire.co.uk/news-releases/pain-monitoring-technology-nol-is-shown-to-reduce-postoperative-pain-and-health-costs-819202235.html","source":"www.prnewswire.co.uk","visible":1,"analysis":{"tags":"pain monitoring technology","company":"Medasense","layoffs":null,"summary":"A study from Leiden University in the Netherlands has found that using NOL technology from Medasense during surgery can help reduce postoperative pain, which can potentially reduce healthcare costs. The study demonstrated that patient pain scores were 33% lower when pain medication during surgery was guided with NOL monitoring. An economic analysis conducted by Coreva Scientific found that these positive outcomes could lead to a 22% reduction in healthcare costs associated with acute postoperative pain treatments. Additionally, there could be a 6% reduction in the expected number of patients receiving postoperative opioid prescriptions. Medasense offers the PMD-200 with NOL index, a non-invasive pain monitoring technology that allows clinicians to optimize and personalize pain control.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["NOL technology","postoperative pain","healthcare costs","pain medication","economic analysis"],"date_of_event":"2021-04-27","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YSvZbTsAOR6gytmSV7IuQ0aGQ0Sq3P786aoxJUOCeGjZR6TWFXPOkR","news_summary":"Pain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"32d7c6f1-887d-4240-98ed-8cd7f5e920f0","date":"Oct 28, 2020","link":"https://www.prnewswire.com/il/news-releases/nol-pain-response-monitoring-secures-marketing-approval-in-brazil-853688474.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical technology","company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Medasense Biometrics Ltd.s NOL pain response monitoring device has been approved for marketing in Brazil by ANVISA. The device helps surgical teams manage pain medication during surgery and applies a non-invasive sensing platform and AI algorithm to monitor and quantify the patients pain response. Studies are also being conducted to confirm the benefits of NOL monitoring in the intensive care unit for mechanically ventilated patients, including COVID-19 patients. Medasense has partnered with J.G. Moriya to establish NOL monitoring in Brazil and expects to perform the first NOL-guided surgeries in the coming weeks.","partners":"J.G. Moriya","customers":null,"investors":null,"confidence":9,"key_topics":["NOL pain response monitoring device","approval for marketing in Brazil","benefits of NOL monitoring in the intensive care unit","partnership with J.G. Moriya","expansion into Brazil"],"date_of_event":"October 28, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"K6enYWcD3qryvIXA9Ke5nOEauKivyfPTx0AjMUjpljp9V7wZgePUGS","news_summary":"NOL Pain Response Monitoring Secures Marketing Approval in Brazil","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"620669d4-9677-4242-a2a3-8a92b219d63a","date":"Oct 13, 2020","link":"https://www.israel21c.org/unique-pain-monitor-during-surgery-reduces-post-op-pain/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"pain response monitoring","company":"Medasense","layoffs":null,"summary":"A study in the British Journal of Anaesthesia shows that Medasenses pain response monitoring technology can help reduce postoperative pain. The device uses artificial intelligence and a noninvasive sensor platform to objectively monitor and quantify patients pain response. The study found that postoperative patient pain scores were one-third lower when pain medication during surgery was guided by the Medasense device. Additionally, stress hormone levels were up to 50 percent lower in these patients. Medasense recently raised $18 million in a series C round and is seeking FDA approval for commercialization in the United States.","partners":["Medtronic","Philips"],"customers":null,"investors":null,"confidence":8,"key_topics":["pain response monitoring","artificial intelligence","postoperative pain","surgical procedures","FDA approval"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"x30zbqlxbAruFwMgUdvT6Ra09QGCH6UsnGPIY5VYhDLPM67VjZTA0e","news_summary":"Unique pain monitor during surgery reduces post-op pain","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"54a31540-9d0f-4f50-8264-c6f7b27a26e4","date":"Sep 22, 2020","link":"https://en.globes.co.il/en/article-israeli-pain-monitoring-co-medasense-raises-18m-1001343374","source":"en.globes.co.il","visible":1,"analysis":{"tags":"pain response monitoring","company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Medasense Biometrics Ltd., an Israeli pain response monitoring company, has raised $18 million in a series C round of funding. The funding was provided by Sabadell Asabys venture capital firm, Israeli family offices, and returning investors Baxter Ventures, Olive Tree Ventures, and LGL Capital. Medasenses technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patients Signature of Pain. The technology is currently used in operating rooms and critical care settings, enabling clinicians to personalize treatment and control pain. The company plans to expand its commercial deployment in Europe and obtain FDA approval for commercialization in the US. Medasense aims to improve pain care and reduce healthcare costs associated with postoperative pain.","partners":"Medtronic","customers":null,"investors":"Sabadell Asabys venture capital firm, Baxter Ventures, Olive Tree Ventures, LGL Capital","confidence":9,"key_topics":["Medasense","technology","pain management","investment","FDA approval"],"date_of_event":"September 22, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$18 million","structured_issues":["Investment","Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XYjCPJLobw0Bo6G7ukU845kKXwo5vnWDqx63ijzctdozwmoalgocfz","news_summary":"Israeli pain monitoring co Medasense raises $18m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a178a91d-ac02-4e52-ade1-a91a37bf3bae","date":"Sep 17, 2020","link":"https://www.prnewswire.com/il/news-releases/analysis-shows-cost-benefits-of-personalizing-pain-management-during-surgery-with-nol-technology--ai-tech-301133216.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"AI, healthcare","company":"Medasense","layoffs":null,"summary":"A new economic study has shown that Medasenses AI-based pain-response monitoring solution, NOL technology, is likely to help reduce the cost of care for hospitals. The study demonstrated that NOL-guided intraoperative analgesia could facilitate cost savings in under a year. NOL monitoring provides a reliable index for the surgical team to objectively detect and quantify noxious stimuli during anesthesia. The research showed that ROI could be achieved within two to five months, and depending on the country, savings of $218,000 to $417,000 in hospital expenses could be reached within one year. The study aims to increase adoption of NOL monitoring in surgical facilities.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["AI tools","NOL technology","cost savings","pain-response monitoring","surgical facilities"],"date_of_event":"2020-09-17","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"461pGtwFFPH82AsH3vtecoeXgPWiwi0Y3JBEuLb3lQpBoMUK0hIvMd","news_summary":"Analysis Shows Cost Benefits of Personalizing Pain Management During Surgery with NOL Technology - AI Tech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4e764dde-e277-4c7b-8025-281181534d49","date":"May 19, 2020","link":"https://www.prnewswire.com/news-releases/study-validates-nol-technology-for-assessment-of-pain-in-mechanically-ventilated-patients-301061559.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["pain management","ICU","NOL monitoring","observational study"],"company":"Medasense","layoffs":null,"summary":"The peer-reviewed journal Pain Management Nursing has published the results of an observational study exploring the utilization of NOL® monitoring to assess pain response levels experienced by mechanically ventilated patients in the ICU. The study found that the NOL index can identify and quantify different levels of painful stimuli in these patients. Medasense, the company behind NOL technology, sees the potential value of NOL monitoring in the ICU and is conducting additional studies to confirm its benefits. The use of objective pain monitors, specifically the NOL, is recommended by recent ICU guidelines for deeply sedated and intubated COVID-19 patients.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["NOL monitoring","pain management","ICU","observational study","Medasense"],"date_of_event":"May 19, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"AoKnOUDOCksGGiQp3IqRP06UeZANXuqCjqLoIzo026npwuo96fMal7","news_summary":"Study Validates NOL Technology for Assessment of Pain in Mechanically Ventilated Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d4aa0154-1687-4410-add4-7a012a30d837","date":"Dec 19, 2019","link":"https://www.prnewswire.com/news-releases/medasense-to-provide-pain-index-solution-for-treatment-of-dementia-patients-300977551.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"pain response monitoring","company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Medasense Biometrics Ltd. has been awarded a development grant from the Israel Innovation Authority to extend the application of its NOL pain response monitoring index for noncommunicating dementia patients. The project will be conducted in collaboration with the Dorot Rehabilitation and Geriatric Medical Center in Netanya, Israel. The grant will enable Medasense to provide tools that can help reduce suffering for dementia patients and improve pain care and patient outcomes. Medasenses NOL technology enables clinicians to optimize and personalize pain control and avoid overmedication. The companys flagship product, the PMD-200 with its NOL index, is a unique platform that objectively monitors and quantifies the patients pain response. The companys pipeline cloud-based solutions for clinics and home address a $15B global market.","partners":["Dorot Rehabilitation and Geriatric Medical Center"],"customers":null,"investors":null,"confidence":8,"key_topics":["development grant","NOL pain response monitoring","noncommunicating dementia patients","pain control","collaboration"],"date_of_event":"2019-12-19","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CswqzNPoeBPNsG5ONp9r26oGzuFApYxmeWtzJrnlfEGt45rg6WxwO9","news_summary":"Medasense to Provide Pain Index Solution for Treatment of Dementia Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5fabfa0f-125d-4a90-947f-ca54532cac42","date":"Jul 22, 2019","link":"https://www.israel21c.org/israeli-companies-chosen-for-medtech-innovator-showcase/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"medical technology","company":"Medasense, Vectorious","layoffs":null,"summary":"Israeli biomed companies Medasense and Vectorious have been selected for MedTech Innovators 2019 Showcase program. Medasense was chosen for its AI-driven pain-management technology, while Vectorious was selected for its V-LAP product for heart failure monitoring. The companies were among 50 finalists chosen out of 800 applicants. The showcase program provides an opportunity for these companies to present their innovations on stage. Additionally, Israeli company ApiFix, which developed a minimally invasive procedure for correcting adolescent scoliosis, won a grant and access to an accelerator program.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["MedTech Innovator","Medical Device Conference","AI-driven pain-management technology","V-LAP product","Adolescent scoliosis correction"],"date_of_event":"June 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LuuEBmtqPOsut2Gs3enTXRLWsyzXgI8aG7yy2atk4eUVP2rsy0pTRE","news_summary":"Israeli companies chosen for MedTech Innovator Showcase","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5fabfa0f-125d-4a90-947f-ca54532cac42","date":"Jul 22, 2019","link":"https://www.israel21c.org/israeli-companies-chosen-for-medtech-innovator-showcase/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"biomed, technology","company":"Medasense, Vectorious","layoffs":null,"summary":"Israeli biomed companies Medasense and Vectorious have been selected for MedTech Innovators 2019 Showcase program. Medasense was chosen for its AI-driven pain-management technology, while Vectorious was chosen for its V-LAP product for heart failure monitoring. The companies were among 50 finalists selected out of 800 applicants. The showcase program provides an opportunity for startups to present their technologies on stage. Additionally, Israeli company ApiFix, which developed a minimally invasive procedure for correcting adolescent scoliosis, won a grant and access to a Pediatric Device Innovator Accelerator Program.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["MedTech Innovator","Medical Device Conference","AI-driven pain-management technology","V-LAP product","Adolescent scoliosis correction"],"date_of_event":"September 23-25, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yuGqTDuYD1iNVmhWbwseQzg1o4pfIlHMVOciG3Env3uHQEFiIG66Hu","news_summary":"Israeli companies chosen for MedTech Innovator Showcase","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"585d6c9a-f481-45ed-aadb-78abacc3a42f","date":"Apr 22, 2019","link":"http://nocamels.com/2019/04/an-israeli-pain-technology-could-ebb-opioid-addiction-post-surgery/","source":"nocamels.com","visible":1,"analysis":{"tags":"pain assessment","company":"Medasense Biometrics","layoffs":null,"summary":"Medasense Biometrics, an Israeli company, has developed a portable pain sensor that uses artificial intelligence algorithms to objectively assess a patients physiological response to pain. The technology aims to reduce opioid addiction post-surgery by providing doctors with real-time data on a patients pain levels and pain care needs. The companys pain sensor has already shown promising results, with a recent study reporting a 30% reduction in opioid consumption during surgery. Medasenses pain technology is commercially available in Europe, Canada, Australia, and Israel, and the company is working to enter the US market. The goal is to help curb the opioid crisis by providing personalized and optimized pain care.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["opioid addiction","pain sensor","precision medicine","artificial intelligence","Medasense technology"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"m3RswvqO4pfe5xRwHY9sLp0bt3GVbx5JkIIsHSqFJLwKZjFBR3RyGf","news_summary":"An Israeli Pain Technology Could Ebb Opioid Addiction Post-Surgery","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1c3d9d34-60e5-4455-b484-3251800ce80d","date":"Jan 8, 2019","link":"https://www.prnewswire.com/il/news-releases/medasense-announces-compatibility-with-philips-intellivue-patient-monitors-846681408.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"pain-response monitoring","company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Medasense Biometrics Ltd. now supports Philips IntelliVue Patient Monitors for anesthesia and critical care monitoring. The partnership with Philips marks new ground in making Medasenses NOL technology the new standard of care for pain-response monitoring. The PMD-200 monitor and its NOL index help clinicians optimize patients pain management in critical care. The technology enables clinicians to have a reliable, consolidated view of changes in pain response level, integrated within their vital sign monitor and saved into their electronic medical record. Medasense aims to improve patient safety and outcomes by collaborating with industry leaders like Philips.","partners":"Philips","customers":null,"investors":null,"confidence":8,"key_topics":["Medasense Biometrics","PMD-200 monitor","NOL index","Philips IntelliVue Patient Monitors","pain management"],"date_of_event":"January 8, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"djlQZ2ZMZ0rxeLX2EfIq8hnustb4JeLZFGZ7oBAUGRUCaOA97mVB77","news_summary":"Medasense Announces Compatibility with Philips IntelliVue Patient Monitors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b8e0ddef-8069-4a57-a98a-ce4420474fec","date":"Oct 31, 2018","link":"https://www.newswire.ca/news-releases/medasense-announces-positive-results-from-clinical-outcome-studies-using-the-nol-monitoring-technology-for-optimized-pain-control-699140121.html","source":"www.newswire.ca","visible":1,"analysis":{"tags":["pain assessment","NOL technology","opioid administration","patient outcomes"],"company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Medasense Biometrics Ltd., developer of innovative systems and applications to objectively assess the physiological response to pain, announced positive results from several studies using the NOL monitoring technology. The studies demonstrated that using the NOL technology significantly reduced opioid consumption and improved hemodynamic stability in patients undergoing major surgery. The first study showed that NOL-guided opioid administration led to 33% less intraoperative opioids and 80% less hemodynamic hypotensive events. The second study found that NOL correlated with pain at mobilization on day 1 following surgery and pain at movement 3 months following surgery. These results indicate the potential of NOL technology to improve patient care and empower clinicians in pain management.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["NOL technology","pain assessment","opioid administration","patient outcomes","surgery"],"date_of_event":"October 31, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ud8TCjPPhRsCQUKrx0xYE6eR1OwT8PngJWFGYfBIKuPzgzArDv0xMf","news_summary":"Medasense Announces Positive Results From Clinical Outcome Studies Using the NOL® Monitoring Technology for Optimized Pain Control","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5014f5bd-2569-4961-bf4f-6fbf067315af","date":"Sep 7, 2017","link":"http://www.flanderstoday.eu/innovation/uz-antwerp-first-objectively-measure-pain","source":"www.flanderstoday.eu","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"bDtEl74LHF1Eh3t6NMrkYxHH0cEbuCKJkauDEXZdp86e6KBzDgyEJt","news_summary":"The Bulletin","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"bd2bea70-f7db-4864-9258-101c90ac6abd","date":"May 23, 2016","link":"http://www.globes.co.il/en/article-baxter-ventures-invests-in-medasense-biometrics-1001126559","source":"www.globes.co.il","visible":1,"analysis":{"tags":"investment","company":"Medasense Biometrics Ltd","layoffs":null,"summary":"Israeli medical device company Medasense Biometrics has received an investment from Baxter Ventures, the investment arm of Baxter International. The investment is part of Medasenses series B financing round and will support global clinical research and market development of their flagship product PMD-200, an objective pain monitoring system. Medasense has developed technology that can assess and monitor changes in a patients pain level by processing physiological parameters affected by pain and analgesic administration. The investment from Baxter Ventures strengthens Medasenses commitment to improving patient care and optimizing pain treatment. The amount of investment has not been disclosed.","partners":null,"customers":null,"investors":["Baxter Ventures","Benslie International Ltd"],"confidence":8,"key_topics":["Israeli startup","technology","patients pain level","investment","clinical research"],"date_of_event":"May 23, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0c4tfFkTZLoJSSzv7wM98m0G6KMQWteAM3aPrVC6PV8wfkxacVl5DP","news_summary":"Baxter Ventures invests in Medasense Biometrics","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6a087c3e-bf1f-4f46-a6a3-ebb089fc8880","date":"Mar 1, 2016","link":"http://www.globes.co.il/en/article-israeli-pain-monitoring-co-medasense-biometrics-raises-8m-1001107287","source":"www.globes.co.il","visible":1,"analysis":{"tags":"pain monitoring","company":"Medasense Biometrics Ltd.","layoffs":null,"summary":"Israeli pain monitoring startup Medasense Biometrics Ltd. has closed an $8 million Series B financing round. The financing was led by Benslie International Ltd. and joined by existing investors and a strategic investor - a leading global medical technology corporation. Medasense will use the new funding to accelerate commercialization of its flagship product PMD-200: An objective pain monitoring system for operating rooms and critical care. The system consists of a non-invasive finger probe that records multiple pain-related physiological signals, and the PMD-200 monitor, which uses a composite algorithm to determine an individuals real-time pain level index NoL. The technology has been validated in clinical studies and outperforms currently used parameters and methods.","partners":null,"customers":null,"investors":"Benslie International Ltd.","confidence":9,"key_topics":["pain monitoring","Series B financing","objective pain assessment","commercialization","clinical studies"],"date_of_event":"March 1, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"mStfJawZMlNjmPrtRdeCcKjU95BqXFYf6Zp8HjZzMU0ZXvvVfrZKYa","news_summary":"Pain monitoring co Medasense Biometrics raises $8m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7852a97b-7213-4c9c-829b-fc1210fd1f15","date":"May 19, 2015","link":"http://nocamels.com/2015/05/medasenses-pain-assessment-monitor/","source":"nocamels.com","visible":1,"analysis":{"tags":"pain monitoring","company":"Medasense","layoffs":null,"summary":"Israeli biomed startup Medasense has developed a technology that mathematically measures pain to help doctors assess patients. The companys flagship product is a non-invasive pain monitoring device that uses statistical tools to give an objective pain reading. The device is expected to receive approval from the EU in the coming months. Medasense has raised $5 million in private rounds. The company was announced as one of the winners of the startup competition at the Israel Advanced Technology Industries (IATI) Biomed Conference.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["pain monitoring","Medasense","technology","algorithm","startup competition"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rglqW82JwQGFQmR1gpUSOwoOOkVC2LwSrMEO534agyPDCNnB9c7akA","news_summary":"Medasense's Pain Assessment Monitor Among Winners Of Prestigious Startup Competition","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":16,"techcommunityinvolvement":null,"mediagallery":[{"id":"n0UouvEiLfXuKdxcTTO0N7pXV5oFjVIH3rRShWegfR5JE99fKPOVAf","timestamp":"2024-02-25 14:55:39.000000","resources_type":2,"resources_title":"","resources_file_name":"WcD8sjBafvg","alt":"","imageurl":"https://img.youtube.com/vi/WcD8sjBafvg/0.jpg","url":"http://youtu.be/WcD8sjBafvg"},{"id":"2945ae18-c6fb-4222-b4bf-d2c17eb82ed2","timestamp":"2020-10-19 08:24:22.000000","resources_type":2,"resources_title":"Reducing Postoperative Pain Scores: NOL Monitoring During Anaesthesia","resources_file_name":"NB4Zwx6ir98","alt":"Reducing Postoperative Pain Scores: NOL Monitoring During Anaesthesia logo","imageurl":"https://img.youtube.com/vi/NB4Zwx6ir98/0.jpg","url":"http://youtu.be/NB4Zwx6ir98"},{"id":"ece90c5b-afff-4a21-ae80-1ae1b509c033","timestamp":"2020-01-13 18:24:56.000000","resources_type":2,"resources_title":"The Essence of Medasense | Confident Pain Management","resources_file_name":"-JQevE0Vgl4","alt":"The Essence of Medasense | Confident Pain Management logo","imageurl":"https://img.youtube.com/vi/-JQevE0Vgl4/0.jpg","url":"http://youtu.be/-JQevE0Vgl4"},{"id":"a1950050-32ad-4d3e-8bc4-6d88eecdf868","timestamp":"2020-01-13 18:24:49.000000","resources_type":2,"resources_title":"Medasense - PMD-200 - Pain Monitoring Solutions","resources_file_name":"96746lf5JYg","alt":"Medasense - PMD-200 - Pain Monitoring Solutions logo","imageurl":"https://img.youtube.com/vi/96746lf5JYg/0.jpg","url":"http://youtu.be/96746lf5JYg"},{"id":"79b1371e-aecd-45a0-bdd8-452f4fb0e1c2","timestamp":"2020-01-13 18:16:19.000000","resources_type":2,"resources_title":"Leading Clinicians on the Importance of Pain Response (Nociception) Monitoring","resources_file_name":"pv5Ank2DGkM","alt":"Leading Clinicians on the Importance of Pain Response (Nociception) Monitoring logo","imageurl":"https://img.youtube.com/vi/pv5Ank2DGkM/0.jpg","url":"http://youtu.be/pv5Ank2DGkM"},{"id":"5ac0c305-bf1c-494c-9d47-d227bdb18785","timestamp":"2020-01-13 18:15:09.000000","resources_type":2,"resources_title":"Results of NOL Outcomes Studies ","resources_file_name":"Moj6botjqeU","alt":"Results of NOL Outcomes Studies  logo","imageurl":"https://img.youtube.com/vi/Moj6botjqeU/0.jpg","url":"http://youtu.be/Moj6botjqeU"}],"tags":["digital-healthcare","real-time","patient-care","medical-devices","non-invasive","measurements","physiological-parameters","sensors","artificial-intelligence","monitoring","data-analytics","critical-care","surgery","surgeons","pain-free","doctors","clinics","healthcare-providers","hospitals","medical-technologies","healthcare","diagnostics","early-detection","remote-monitoring"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo5OcKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Mf_ipULDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["NOL Index","NOLedge","PMD-200"],"geomarkets":["Canada","Brazil","South Africa","South America","Australia","Europe","Turkey","United States","Israel"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":9,"lastfunding":"Undisclosed","totalrounds":5,"fundingstage":"C","totalfunding":"$33.5M","publicinvestors":9,"lastpublicfunding":0,"totalpublicrounds":5,"totalpublicfunding":33500000},"team":[{"name":"Walter Tabachnik","email":"wtabachnik@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN6Q_4YIDA","bounced":false,"claimed":1,"founder":0,"urlname":"walter-tabachnik-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd-E2QgM","position":"Board Member & CFO","last_name":"Tabachnik","claimtoken":"c666c35be82b29e9f28a0b5477bc893c0580d23de868aed8ba8648db18458a0c","first_name":"Walter","picturekey":null,"claimeddate":"2014-12-31","linkedinurl":"https://www.linkedin.com/in/waltertabachnik","unsubscribed":false,"is_activeuser":0,"additionalemail":"walter@medasense.com","claimedemaildate":null,"initials":"WT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Galit Zuckerman","email":"galit@medasense.com","phone":"054-631-2108","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN72r5AJDA","bounced":false,"claimed":1,"founder":1,"urlname":"galit-zuckerman-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA0dK16ggM","position":"Co-founder & CEO","last_name":"Zuckerman","claimtoken":"4eee225645c42d1d46b7059f4c5e326ad75ac13d5d8bf081d5f0566da31dd4d4","first_name":"Galit","picturekey":"$MuOD7ePqAmDyUCzRnQRPrAbeGtBF0LsLbKKXfqE9zfr3uioBPlpJXS","claimeddate":"2014-07-13","linkedinurl":"https://www.linkedin.com/in/galitzuckerman","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$MuOD7ePqAmDyUCzRnQRPrAbeGtBF0LsLbKKXfqE9zfr3uioBPlpJXS","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Rachel Weissbrod","email":"rachel@medasense.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4MbrjMwIDA","bounced":false,"claimed":0,"founder":0,"urlname":"rachel-weissbrod","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgpo_gkQkM","position":"VP Clinical & Market Development","last_name":"Weissbrod","claimtoken":"iqMwPGf76SfuwOMo2ZCV1XnI5XYB0zjvpBxKKJf6KPoQb2qWp2NiDu","first_name":"Rachel","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/rachel-weissbrod-628b095/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-08-29 14:11:06.000000","initials":"RW","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-05-21T00:00:00.000Z","crunchbaseid":"medasense-biometrics-ltd--2","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-06-24T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"eIPScM9nZcaLkJnhodru8NPjlGT5Gohfn5S5LpvCevVj8In2Nt1GXB","date":"Jan 2025","amount":"Undisclosed","source":"https://www.calcalistech.com/ctechnews/article/syfylqjd1l","eventtype":"FundingRoundEvent","investment":[{"name":"BIRD Foundation","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/bird-foundation-1","logokey":"$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","tagline":null,"urlname":"/investor_page/bird-foundation-1","isisraeli":1,"investorid":"wkYw2Xa6wWAx2YsZ9ibCjlofkfLroUdqV57jv9Cfoi5vsESiKKOHLp","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"1v8iD3LK0oqrm5Db7DGHVsuEpSVeKVbiHZRESubPVrz3Ga5NMNfOEA","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"hqQmUeDOsEFfICPLJPNYQTSQRd6AWjl9nOAioHoD8QqWscjt0g4CTU","hub":"Deloitte Launchpad","date":"Apr 2023","batch":"5","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4IOWkJ4JDA","source":"https://www.calcalistech.com/ctechnews/article/hjt7fotg3","enddate":"Jul 2023","hub_type":"Corporate Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/deloitte-launchpad","hub_logokey":"$5IVu6XNJK9wtMy1GGBeh8oW66e8aJfDgUZ3X1Myr8gG5bKYCvTvUkV","hub_urlname":"/program_page/deloitte-launchpad","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$5IVu6XNJK9wtMy1GGBeh8oW66e8aJfDgUZ3X1Myr8gG5bKYCvTvUkV","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODF6t6ACQw","date":"Sep 2020","amount":"$18M","source":"https://en.globes.co.il/en/article-israeli-pain-monitoring-co-medasense-raises-18m-1001343374","eventtype":"FundingRoundEvent","investment":[{"name":"Sabadell Asabys VC","type":"Investor","amount":0,"hidden":false,"country":"Spain","fullurl":"/investor_page/sabadell-asabys-vc","logokey":null,"tagline":"","urlname":"/investor_page/sabadell-asabys-vc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC545aLCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2b8e1be1-18f7-42b7-93ef-9b83fb94e39b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"OTV","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/olive-tree-ventures","logokey":"$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","tagline":null,"urlname":"/investor_page/olive-tree-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXjwZ0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3b3ac5a5-8b3e-4dba-ba26-5d7ca9662656","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","leadcaption":"","followupcaption":"Follow on "},{"name":"LGL Capital Pty Ltd","type":"Investor","amount":0,"hidden":false,"country":"Australia","fullurl":"/investor_page/lgl-capital-pty-ltd","logokey":null,"tagline":"","urlname":"/investor_page/lgl-capital-pty-ltd","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC6u4_qCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"478f27b6-90dd-4b03-8078-3d191fda8570","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "},{"name":"Baxter Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/baxter-ventures","logokey":"$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","tagline":"","urlname":"/investor_page/baxter-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP3VCQw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"71421516-379e-4ae7-925a-fa896cc2f96a","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":18000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjd7XCgw","date":"Nov 2015","amount":"$10M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"OTV","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/olive-tree-ventures","logokey":"$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","tagline":null,"urlname":"/investor_page/olive-tree-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXjwZ0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3e7fb808-ecef-4fc4-8bce-dd0dcc45fcc5","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","leadcaption":"Lead ","followupcaption":""},{"name":"Baxter Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/baxter-ventures","logokey":"$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","tagline":"","urlname":"/investor_page/baxter-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP3VCQw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"adf2f2a2-5c31-48f2-904d-02d2d412abf3","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCm4pC1CAw","date":"Apr 2012","amount":"$4.5M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"LGL Capital Pty Ltd","type":"Investor","amount":0,"hidden":false,"country":"Australia","fullurl":"/investor_page/lgl-capital-pty-ltd","logokey":null,"tagline":"","urlname":"/investor_page/lgl-capital-pty-ltd","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC6u4_qCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8e0ed503-bbb8-40aa-9284-f35fc3f87909","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Medoc","type":"Startup","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/medoc","logokey":"$rINliwoGogyeOyKmTiyRoEjttGN7mujIUrMegllFPlKYFbYFXPydaj.jpeg","tagline":"Pain Assessment and Monitoring Systems","urlname":"/company_page/medoc","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6LoJwKDA","fundingtype":"Startup","leadpartner":null,"investmentid":"ef35319b-0a86-4e35-a3f6-fc853a729e95","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rINliwoGogyeOyKmTiyRoEjttGN7mujIUrMegllFPlKYFbYFXPydaj.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCm0sq5CAw","date":"Jul 2008","amount":"$1M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"Shmuel Cabilly","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/shmuel-cabilly","logokey":"$ByIlkmN3MYiCH7QjUV39OpRbruBOVERDtnhhy0CbRHNXVpR1IMQo4F","tagline":null,"urlname":"/investor_page/shmuel-cabilly","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJjNp-MLDA","fundingtype":"Angel","leadpartner":null,"investmentid":"249751a5-9881-4cbd-92e7-1558b58c93bd","fundingsubtype":"Angel","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ByIlkmN3MYiCH7QjUV39OpRbruBOVERDtnhhy0CbRHNXVpR1IMQo4F","leadcaption":"Lead ","followupcaption":""},{"name":"Ofakim Hi-Tech Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofakim-hi-tech-ventures","logokey":"$wrgST7nUAyEeMNCAUVHMqU8FX0iKgqoVFSMnyqg3XSo528IQGV70nP","tagline":"","urlname":"/investor_page/ofakim-hi-tech-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCko8TdCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2b3852db-e3ea-40e1-a47d-05f544090bce","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wrgST7nUAyEeMNCAUVHMqU8FX0iKgqoVFSMnyqg3XSo528IQGV70nP","leadcaption":"","followupcaption":""},{"name":"Capital Point","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/capital-point","logokey":"$nbtdEYXbRTDnzAKQKTPaWxwQiMSXCQl3X8a3YvKZEqEGHKsCZtLrpT","tagline":null,"urlname":"/investor_page/capital-point","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGM6oMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"733a083c-f064-4c3e-b611-53b07bf3c366","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nbtdEYXbRTDnzAKQKTPaWxwQiMSXCQl3X8a3YvKZEqEGHKsCZtLrpT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"4tJw01yii6ehWJv47bLZSubBhaLSBYMGGYNu5a5a8UpQMRMnG5vtfL","hub":"8200EISP","date":"","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNWA8o0KDA","source":"","enddate":"","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/company_page/8200eisp","hub_logokey":"$pY4zEuSrjCeJd7Itx7SY5gxqRbEhBGkxfMsKiZYgn9k9530PQjt89j","hub_urlname":"/company_page/8200eisp","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$pY4zEuSrjCeJd7Itx7SY5gxqRbEhBGkxfMsKiZYgn9k9530PQjt89j","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2008","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Medasense Biometrics","logourl":"https://storage.googleapis.com/clean-finder-353810/$yhgor0aajGD4VqHAyFBWekT83A0RekNKmhdy5KT9iKdtutjy4bWPal","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$yhgor0aajGD4VqHAyFBWekT83A0RekNKmhdy5KT9iKdtutjy4bWPal","seoabout":"Medasense offers a technology that enables clinicians to optimize and personalize pain control and avoid overmedication.\r\n\r\nMedasense's flagship product, t...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Monitors","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo5OcKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Biometrics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Mf_ipULDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Monitors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo5OcKDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA>Biometrics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Mf_ipULDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Monitors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo5OcKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|2:>TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA/Biometrics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Mf_ipULDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Patient Remote Monitoring","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Patient Remote Monitoring"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Monitors","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Monitors"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence"},{"title":"Sensing","key":"0-1","path":"TechnologyClassificationModel>Sensing","children":[{"title":"Biometrics","key":"0-1-0","path":"TechnologyClassificationModel>Sensing>Biometrics"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Monitors","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo5OcKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Biometrics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Mf_ipULDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Patient Remote Monitoring","Medical Devices","Medical Monitors"],"coreTechnology":["Artificial Intelligence","Sensing","Biometrics"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"eIPScM9nZcaLkJnhodru8NPjlGT5Gohfn5S5LpvCevVj8In2Nt1GXB","date":"Jan 2025","amount":"Undisclosed","source":"https://www.calcalistech.com/ctechnews/article/syfylqjd1l","eventtype":"FundingRoundEvent","investment":[{"name":"BIRD Foundation","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/bird-foundation-1","logokey":"$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","tagline":null,"urlname":"/investor_page/bird-foundation-1","isisraeli":1,"investorid":"wkYw2Xa6wWAx2YsZ9ibCjlofkfLroUdqV57jv9Cfoi5vsESiKKOHLp","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"1v8iD3LK0oqrm5Db7DGHVsuEpSVeKVbiHZRESubPVrz3Ga5NMNfOEA","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODF6t6ACQw","date":"Sep 2020","amount":"$18M","source":"https://en.globes.co.il/en/article-israeli-pain-monitoring-co-medasense-raises-18m-1001343374","eventtype":"FundingRoundEvent","investment":[{"name":"Sabadell Asabys VC","type":"Investor","amount":0,"hidden":false,"country":"Spain","fullurl":"/investor_page/sabadell-asabys-vc","logokey":null,"tagline":"","urlname":"/investor_page/sabadell-asabys-vc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC545aLCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2b8e1be1-18f7-42b7-93ef-9b83fb94e39b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"OTV","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/olive-tree-ventures","logokey":"$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","tagline":null,"urlname":"/investor_page/olive-tree-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXjwZ0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3b3ac5a5-8b3e-4dba-ba26-5d7ca9662656","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","leadcaption":"","followupcaption":"Follow on "},{"name":"LGL Capital Pty Ltd","type":"Investor","amount":0,"hidden":false,"country":"Australia","fullurl":"/investor_page/lgl-capital-pty-ltd","logokey":null,"tagline":"","urlname":"/investor_page/lgl-capital-pty-ltd","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC6u4_qCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"478f27b6-90dd-4b03-8078-3d191fda8570","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":"Follow on "},{"name":"Baxter Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/baxter-ventures","logokey":"$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","tagline":"","urlname":"/investor_page/baxter-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP3VCQw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"71421516-379e-4ae7-925a-fa896cc2f96a","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":18000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjd7XCgw","date":"Nov 2015","amount":"$10M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"OTV","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/olive-tree-ventures","logokey":"$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","tagline":null,"urlname":"/investor_page/olive-tree-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXjwZ0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3e7fb808-ecef-4fc4-8bce-dd0dcc45fcc5","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S61zBRqQ6h0Osg5ctqDoTof8NWGHIpRCmPIerGtMsJZODtZ2f8MMs4","leadcaption":"Lead ","followupcaption":""},{"name":"Baxter Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/baxter-ventures","logokey":"$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","tagline":"","urlname":"/investor_page/baxter-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP3VCQw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"adf2f2a2-5c31-48f2-904d-02d2d412abf3","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CGkzmPhc9CTp1tVAtivHB1tXt1WJ6fhZTC1KptNwMIBzGGKeOgVf7C","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCm4pC1CAw","date":"Apr 2012","amount":"$4.5M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"LGL Capital Pty Ltd","type":"Investor","amount":0,"hidden":false,"country":"Australia","fullurl":"/investor_page/lgl-capital-pty-ltd","logokey":null,"tagline":"","urlname":"/investor_page/lgl-capital-pty-ltd","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC6u4_qCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8e0ed503-bbb8-40aa-9284-f35fc3f87909","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Medoc","type":"Startup","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/medoc","logokey":"$rINliwoGogyeOyKmTiyRoEjttGN7mujIUrMegllFPlKYFbYFXPydaj.jpeg","tagline":"Pain Assessment and Monitoring Systems","urlname":"/company_page/medoc","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6LoJwKDA","fundingtype":"Startup","leadpartner":null,"investmentid":"ef35319b-0a86-4e35-a3f6-fc853a729e95","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rINliwoGogyeOyKmTiyRoEjttGN7mujIUrMegllFPlKYFbYFXPydaj.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCm0sq5CAw","date":"Jul 2008","amount":"$1M","source":"Added by Rachel Feldman","eventtype":"FundingRoundEvent","investment":[{"name":"Shmuel Cabilly","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/shmuel-cabilly","logokey":"$ByIlkmN3MYiCH7QjUV39OpRbruBOVERDtnhhy0CbRHNXVpR1IMQo4F","tagline":null,"urlname":"/investor_page/shmuel-cabilly","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJjNp-MLDA","fundingtype":"Angel","leadpartner":null,"investmentid":"249751a5-9881-4cbd-92e7-1558b58c93bd","fundingsubtype":"Angel","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ByIlkmN3MYiCH7QjUV39OpRbruBOVERDtnhhy0CbRHNXVpR1IMQo4F","leadcaption":"Lead ","followupcaption":""},{"name":"Ofakim Hi-Tech Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/ofakim-hi-tech-ventures","logokey":"$wrgST7nUAyEeMNCAUVHMqU8FX0iKgqoVFSMnyqg3XSo528IQGV70nP","tagline":"","urlname":"/investor_page/ofakim-hi-tech-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCko8TdCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2b3852db-e3ea-40e1-a47d-05f544090bce","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wrgST7nUAyEeMNCAUVHMqU8FX0iKgqoVFSMnyqg3XSo528IQGV70nP","leadcaption":"","followupcaption":""},{"name":"Capital Point","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/capital-point","logokey":"$nbtdEYXbRTDnzAKQKTPaWxwQiMSXCQl3X8a3YvKZEqEGHKsCZtLrpT","tagline":null,"urlname":"/investor_page/capital-point","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGM6oMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"733a083c-f064-4c3e-b611-53b07bf3c366","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nbtdEYXbRTDnzAKQKTPaWxwQiMSXCQl3X8a3YvKZEqEGHKsCZtLrpT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}